LIGHTPATH TECHNOLOGIES INC
For the period ended Sep 30, 2026. Filed Nov 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 10, 2026
LPTH$7.99-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Cash Flows
| Three Months Ended | ||
|---|---|---|
| September 30, | ||
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net loss | $(1,700,754) | $(2,893,002) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 1,479,568 | 1,218,948 |
| Interest from amortization of loan issuance costs | — | 38,312 |
| Amortization of fair value of loan | — | 52,544 |
| Change in fair value of acquisition earnout liabilities | 196,633 | 1,282,529 |
| Loss on disposal of property and equipment | 30,849 | 3,999 |
| Stock-based compensation on stock options, RSUs & RSAs, net | 1,801,199 | 359,661 |
| Provision for credit losses | 48,827 | (5,390) |
| Change in operating lease assets and liabilities | (18,687) | (60,448) |
| Inventory write-offs to allowance | 46,512 | — |
| Deferred taxes | 910 | 555 |
| Changes in operating assets and liabilities, net of acquisitions: | ||
| Trade accounts receivable | (118,609) | (133,679) |
| Other current assets | (16,506) | 27,800 |
| Inventories | (13,527,486) | (3,335) |
| Prepaid expenses and deposits | 993,394 | 127,786 |
| Accounts payable and accrued liabilities | 2,457,858 | (1,159,122) |
| Net cash used in operating activities | (8,326,292) | (1,142,842) |
| Cash flows from investing activities: | ||
| Purchase of property and equipment | (2,525,423) | (77,014) |
| Net cash used in investing activities | (2,525,423) | (77,014) |
| Cash flows from financing activities: | ||
| Proceeds from sale of common stock from Employee Stock Purchase Plan | 44,357 | — |
| Proceeds from issuance of common stock under private equity placement, net of fees | — | 7,894,045 |
| Proceeds from sale-leaseback of equipment | 591,974 | — |
| Payments on loans payable | (28,291) | (57,107) |
| Repayment of finance lease obligations | (77,258) | (55,398) |
| Net cash provided by financing activities | 530,782 | 7,781,540 |
| Effect of exchange rate on cash and cash equivalents | 50,443 | 68,698 |
| Change in cash and cash equivalents | (10,270,490) | 6,630,382 |
| Cash and cash equivalents, beginning of period | 93,204,655 | 4,877,036 |
| Cash and cash equivalents, end of period | $82,934,165 | $11,507,418 |
| Supplemental disclosure of cash flow information: | ||
| Interest paid in cash | $24,358 | $177,963 |
| Income taxes paid | $222,352 | $56,282 |
| Supplemental disclosure of non-cash investing & financing activities: | ||
| Issuance of common stock for acquisition of AML, including earnouts | $1,622,879 | — |
| Operating right-of-use assets acquired in exchange for operating lease liabilities | — | $435,733 |
| Issuance of common stock for acquisition of Visimid | — | $350,000 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.